Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Sell
Debt to Equity Rating
Buy
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Wall Street Data Solutions Rating
Neutral
B
Xtant Medical Holdings, Inc. (XTNT)
Biological Products, (no Disgnostic Substances)
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
664 CRUISER LANE
BELGRADE, MT
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/31/2007
Market Cap
80,779,807
Shares Outstanding
130,110,000
Weighted SO
130,110,250
Total Employees
N/A
Upcoming Earnings
08/06/2024
Beta
0.3720
Last Div
0.0000
Range
0.55-1.45
Chg
0.0176
Avg Vol
89204
Mkt Cap
80779807
Exch
AMEX
Country
US
Phone
406 388 0480
DCF Diff
1.5061
DCF
-0.4561
Div Yield
0.0000
P/S
0.7281
EV Multiple
-10.4175
P/FV
1.7949
Div Yield %
0.0000
P/E
-24.2365
PEG
-2.0001
Payout
0.0000
Current Ratio
2.4362
Quick Ratio
1.0054
Cash Ratio
0.1935
DSO
69.7048
DIO
347.1648
Op Cycle
416.8696
DPO
58.9221
CCC
357.9475
Gross Margin
0.6161
Op Margin
-0.1226
Pretax Margin
-0.0446
Net Margin
-0.0300
Eff Tax Rate
-0.6020
ROA
-0.0349
ROE
-0.0671
ROCE
-0.2023
NI/EBT
0.6731
EBT/EBIT
0.3639
EBIT/Rev
-0.1226
Debt Ratio
0.3613
D/E
0.7672
LT Debt/Cap
0.3260
Total Debt/Cap
0.4341
Int Coverage
137.4444
CF/Debt
-0.4515
Equity Multi
2.1237
Rec Turnover
5.2364
Pay Turnover
6.1946
Inv Turnover
1.0514
FA Turnover
11.1456
Asset Turnover
1.1608
OCF/Share
-0.1197
FCF/Share
-0.1345
Cash/Share
0.0421
OCF/Sales
-0.1405
FCF/OCF
1.1233
CF Coverage
-0.4515
ST Coverage
-1.2219
CapEx Coverage
-8.1082
Div&CapEx Cov
-8.1082
P/BV
1.7949
P/B
1.7949
P/S
0.7281
P/E
-24.2365
P/FCF
-4.6120
P/OCF
-5.1809
P/CF
-5.1809
PEG
-2.0001
P/S
0.7281
EV Multiple
-10.4175
P/FV
1.7949
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 28.11M | ▼ 27.87M |
Cost Of Revenue | XXXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 10.97M | ▼ 10.57M |
Gross Profit | XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ 17.14M | ▲ 17.30M |
Gross Profit Ratio | X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ 0.61 | ▲ 0.62 |
Research And Development Expenses | XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ 492.00K | ▲ 527.00K |
General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ 8.87M | ▼ 7.79M |
Selling And Marketing Expenses | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ 11.58M | ▲ 12.46M |
Selling General And Administrative Expenses | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 20.45M | ▼ 20.25M |
Other Expenses | -XXXXX | ▼ -XXXXXX | ▲ XXXX | ▼ X | X | 0.00 | ▲ 12.00K |
Operating Expenses | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ 20.94M | ▼ 20.77M |
Cost And Expenses | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 31.91M | ▼ 31.34M |
Interest Income | X | X | X | X | ▲ XXXXX | ▼ 16.00K | ▼ 0.00 |
Interest Expense | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▲ 818.00K | ▲ 835.00K |
Depreciation And Amortization | XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ XXXXX | ▲ 1.02M | ▼ 1.00M |
Ebitda | -XXXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▼ -2.79M | ▲ -2.47M |
Ebitda Ratio | -X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▼ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ -0.10 | ▲ -0.09 |
Operating Income | -XXXXXXXX | ▲ -XXXXXX | ▲ XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▼ -3.81M | ▲ -3.47M |
Operating Income Ratio | -X.XXXXXXXXX | ▲ -X.XXXXXXXXX | ▲ X.XXXXXXXXX | ▼ -X.XXXXXXXXX | ▲ -X.XXXXXXXXX | ▼ -0.14 | ▲ -0.12 |
Total Other Income Expenses Net | -XXXXXXXX | ▲ XXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXXX | ▲ 80.00K | ▼ -862.00K |
Income Before Tax | -XXXXXXXX | ▲ -XXXXXXX | ▲ -XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▼ -3.73M | ▼ -4.33M |
Income Before Tax Ratio | -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▼ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ -0.13 | ▼ -0.16 |
Income Tax Expense | XXXXXXX | ▼ XXXXX | ▲ XXXXXX | ▼ -XXXXX | ▲ XXXXX | ▲ 577.00K | ▼ 68.00K |
Net Income | -XXXXXXXX | ▲ -XXXXXXX | ▲ -XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▼ -4.30M | ▼ -4.40M |
Net Income Ratio | -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▼ -X.XXXXXXXXXX | ▲ -X.XXXXXXXXXX | ▼ -0.15 | ▼ -0.16 |
Eps | -X.XX | ▲ -X.XX | ▲ -X.XX | ▼ -X.XX | ▲ -X.XX | ▼ -0.03 | -0.03 |
Eps Diluted | -X.XX | ▲ -X.XX | ▲ -X.XX | ▼ -X.XX | ▲ -X.XX | ▼ -0.03 | -0.03 |
Weighted Average Shs Out | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ 130.02M | ▲ 130.20M |
Weighted Average Shs Out Dil | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ 130.02M | ▲ 130.20M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 5.92M | ▼ 4.62M |
Short Term Investments | X | X | X | X | X | 0.00 | 0.00 |
Cash And Short Term Investments | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 5.92M | ▼ 4.62M |
Net Receivables | XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ 20.73M | ▲ 21.48M |
Inventory | XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ 36.89M | ▲ 38.72M |
Other Current Assets | XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▲ 1.33M | ▲ 1.71M |
Total Current Assets | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 64.87M | ▲ 66.54M |
Property Plant Equipment Net | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 10.22M | ▲ 10.30M |
Goodwill | XXXXXXX | XXXXXXX | XXXXXXX | XXXXXXX | XXXXXXX | ▲ 7.30M | 7.30M |
Intangible Assets | XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ 10.09M | ▼ 9.65M |
Goodwill And Intangible Assets | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ 17.39M | ▼ 16.95M |
Long Term Investments | X | X | X | X | X | 0.00 | 0.00 |
Tax Assets | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Assets | XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ 141.00K | ▼ 132.00K |
Total Non Current Assets | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 27.74M | ▼ 27.39M |
Other Assets | X | X | X | X | X | ▲ 1.00 | ▼ 0.00 |
Total Assets | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 92.61M | ▲ 93.93M |
Account Payables | XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 7.05M | ▲ 7.38M |
Short Term Debt | XXXXXX | ▲ XXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ 5.52M | ▲ 11.19M |
Tax Payables | X | X | X | X | X | 0.00 | 0.00 |
Deferred Revenue | XXXXXXX | ▲ XXXXXXX | ▼ X | X | X | 0.00 | 0.00 |
Other Current Liabilities | XXXXX | ▼ XXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ 10.42M | ▼ 9.88M |
Total Current Liabilities | XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 22.99M | ▲ 28.44M |
Long Term Debt | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 17.17M | ▼ 16.83M |
Deferred Revenue Non Current | X | X | X | X | X | ▲ 875.00K | ▼ 0.00 |
Deferred Tax Liabilities Non Current | X | X | X | X | X | ▲ 21.00K | ▼ 0.00 |
Other Non Current Liabilities | X | X | X | X | X | ▲ 210.00K | ▲ 983.00K |
Total Non Current Liabilities | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 18.27M | ▼ 17.81M |
Other Liabilities | X | X | X | X | X | 0.00 | ▲ 1.00 |
Capital Lease Obligations | XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ 875.00K | ▼ 743.00K |
Total Liabilities | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 41.26M | ▲ 46.25M |
Preferred Stock | X | X | X | X | X | 0.00 | 0.00 |
Common Stock | X | X | X | X | X | 0.00 | 0.00 |
Retained Earnings | -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▲ -243.01M | ▼ -247.41M |
Accumulated Other Comprehensive Income Loss | -XXXXXXXX | ▼ -XXXXXXXX | ▲ X | X | X | ▲ 29.00K | ▼ -133.00K |
Other Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 294.33M | ▲ 295.22M |
Total Stockholders Equity | -XXXXXXXX | ▼ -XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 51.35M | ▼ 47.68M |
Total Equity | -XXXXXXXX | ▼ -XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 51.35M | ▼ 47.68M |
Total Liabilities And Stockholders Equity | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 92.61M | ▲ 93.93M |
Minority Interest | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities And Total Equity | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 92.61M | ▲ 93.93M |
Total Investments | X | X | X | X | X | 0.00 | 0.00 |
Total Debt | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 23.56M | ▲ 28.76M |
Net Debt | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▲ 17.64M | ▲ 24.13M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -XXXXXXXX | ▲ -XXXXXXX | ▲ -XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▼ -4.30M | ▼ -4.40M |
Depreciation And Amortization | XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▲ 1.02M | ▼ 1.00M |
Deferred Income Tax | XXXXXXXX | ▼ XXXXX | ▼ XXXX | ▲ XXXXXX | ▼ X | ▼ -3.20M | ▲ 0.00 |
Stock Based Compensation | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▲ 938.00K | ▼ 910.00K |
Change In Working Capital | XXXXXXX | ▼ -XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ -XXXXXXX | ▲ 1.35M | ▼ -3.63M |
Accounts Receivables | -XXXXXX | ▼ -XXXXXXX | ▲ XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▼ -1.69M | ▲ -879.00K |
Inventory | XXXXXX | ▼ -XXXXX | ▼ -XXXXXX | ▲ XXXXXXX | ▼ -XXXXXX | ▲ -217.00K | ▼ -2.20M |
Accounts Payables | XXXXXX | ▼ -XXXXX | ▼ -XXXXXX | ▲ XXXXXX | ▼ -XXXXXX | ▲ 1.68M | ▼ 492.00K |
Other Working Capital | XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▲ 1.57M | ▼ -1.05M |
Other Non Cash Items | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▲ 3.28M | ▲ 5.87M |
Net Cash Provided By Operating Activities | XXXXXXX | ▼ -XXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ -XXXXXXX | ▲ -915.00K | ▼ -5.76M |
Investments In Property Plant And Equipment | -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXXX | ▲ -XXXXXX | ▲ -363.00K | ▼ -773.00K |
Acquisitions Net | X | X | X | ▲ XXXXX | ▼ XXXXX | ▼ -1.95M | ▲ 99.00K |
Purchases Of Investments | X | X | X | X | X | 0.00 | 0.00 |
Sales Maturities Of Investments | X | X | X | X | X | 0.00 | 0.00 |
Other Investing Activities | XXXX | ▲ XXXXX | ▼ XXXXX | ▼ XXXXX | ▼ XXXXX | ▲ 105.00K | ▼ 99.00K |
Net Cash Used For Investing Activities | -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXXX | ▼ -2.31M | ▲ -674.00K |
Debt Repayment | -XXXXX | ▲ -XXXXX | ▼ -XXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -155.00K | ▼ -5.63M |
Common Stock Issued | X | X | ▲ XXXXXX | ▼ X | ▲ XXXXXXX | ▼ -4.90M | ▲ -436.00K |
Common Stock Repurchased | X | X | X | ▼ -XXXXXX | ▲ X | ▼ -142.00K | ▲ 0.00 |
Dividends Paid | X | X | X | X | X | 0.00 | 0.00 |
Other Financing Activities | XXXXXX | ▼ XXXX | ▼ -XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 622.00K | ▼ -17.00K |
Net Cash Used Provided By Financing Activities | XXXXX | ▼ -XXXXX | ▼ -XXXXXX | ▲ -XXXXX | ▲ XXXXXXX | ▼ 325.00K | ▲ 5.18M |
Effect Of Forex Changes On Cash | X | X | X | X | X | ▲ 77.00K | ▼ -49.00K |
Net Change In Cash | XXXXXXX | ▼ -XXXXXX | ▲ -XXXXXX | ▲ -XXXXXX | ▲ XXXXXXX | ▼ -2.83M | ▲ -1.30M |
Cash At End Of Period | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 5.92M | ▼ 4.62M |
Cash At Beginning Of Period | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 8.75M | ▼ 5.92M |
Operating Cash Flow | XXXXXXX | ▼ -XXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ -XXXXXXX | ▲ -915.00K | ▼ -5.76M |
Capital Expenditure | -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXXX | ▲ -XXXXXX | ▲ -363.00K | ▼ -773.00K |
Free Cash Flow | XXXXXXX | ▼ -XXXXXX | ▲ XXXXXX | ▼ -XXXXXX | ▼ -XXXXXXX | ▲ -1.28M | ▼ -6.53M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Upgrade To Get Access
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Dicta eveniet ex illo maxime minima numquam quibusdam reprehenderit temporibus vel, voluptatum? Delectus eos eveniet id iusto necessitatibus, neque porro unde voluptatibus. Aut blanditiis commodi, iste iure laborum pariatur temporibus. Atque distinctio dolore, doloremque eaque eius harum inventore laudantium quibusdam recusandae voluptatibus.